biotech

The Biotech Rally Isn’t Over Yet
Barron's
Mon, 09/18/17 - 09:32 am
biotech
Why Amgen, Lilly, J&J Are Interested In These Small Biotechs
Investors Business Daily
Sat, 09/16/17 - 12:11 pm
Amgen
Eli Lilly
JNJ
Exelixis
biotech
Theravance
Bavarian Nordic
Agios
Biohaven Pharmaceuticals
Progenics
3 Biotech Stocks That Have Already Quadrupled in 2017
Stat
Wed, 09/13/17 - 09:33 pm
biotech
Kite Pharma
Sangamo BioSciences
Dynavax Technologies
3 Biotech Stocks That Skyrocketed This Week: Can They Go Higher?
Motley Fool
Sat, 09/9/17 - 02:55 pm
biotech
Insmed
NewLink Genetics
Voyager Therapeutics
ALIS
indoximod/Keytruda
VY-AADC01
Alternative Perspectives On The Biotech M&A Environment
Forbes
Fri, 09/8/17 - 09:31 am
biotech
M&A
R&D
Biotech, pharma chime in over Trump’s move to halt immigration program
Drug Delivery Business News
Wed, 09/6/17 - 10:33 am
biotech
pharma industry
immigration
Decibel Therapeutics
Ovid Therapeutics
Biogen
DACA
Merck, looking to build on cancer success, buys I-O biotech Rigontec
Fierce Biotech
Wed, 09/6/17 - 09:20 am
Merck
M&A
Rigontec
biotech
OrbiMed lines up $551M gamble on China, India biotech sectors
Endpoints
Tue, 09/5/17 - 11:03 am
OrbiMed
China
India
biotech
venture capital
ASCO spotlight presaged two more biotech IPOs angling for $215M
Endpoints
Tue, 09/5/17 - 09:35 am
ASCO
IPOs
biotech
Deciphera
DCC-2618
Nucana
Acelarin
Biotech: Back In Vogue
Barron's
Thu, 08/31/17 - 10:52 am
biotech
biotech stocks
Gilead Sciences
M&A
Kite Pharma
3 Biotech Stocks That Could Soar in September
Motley Fool
Sun, 08/27/17 - 06:26 pm
biotech
fitusiran
Alnylam
PTC Therapeutics
Translarna
Sarepta
Exondys 51
This Biotech Startup Is Using AI To Help Researchers Develop Cures Quicker
Forbes
Sun, 08/20/17 - 11:44 am
biotech
artificial intelligence
Innoplexus
Biotech M&A barely showing sign of a pulse so far in 2017
Endpoints
Fri, 08/18/17 - 12:16 pm
biotech
M&A
Five Reasons Why Biotech Entrepreneurs Absolutely, Positively Need Neil Young, Miles Davis And Liszt
Forbes
Mon, 08/14/17 - 05:37 pm
biotech
innovation
creativity
entrepreneurship
Why Has 2017 Been a Horrible Year So Far for Biotech Acquisitions?
Motley Fool
Mon, 08/14/17 - 10:03 am
biotech
M&A
JNJ
Actelion
Takeda
Ariad Pharmaceuticals
Gilead Sciences
Pfizer
Amgen
Biotech Wunderkind Raises $1.1 Billion To Fund Pharma Startups
Forbes
Wed, 08/9/17 - 11:16 am
startups
biotech
Roivant
Vivek Ramaswamy
Amgen Remains A Standout Among Biotechs
Forbes
Tue, 08/8/17 - 11:55 am
Amgen
Repatha
biotech
These 3 Biotechs Just Crushed Analyst Expectations
Motley Fool
Mon, 08/7/17 - 01:36 pm
biotech
earnings
Sarepta Therapeutics
Biogen
Gilead Sciences
Big Pharma veterans at Pfizer, AstraZeneca join the great migration to biotech
Endpoints
Fri, 08/4/17 - 11:41 am
Pfizer
AstraZeneca
Big Pharma
biotech
3 Biotech Stocks With Big News Coming
Motley Fool
Wed, 08/2/17 - 10:16 am
biotech
Flexion
Zilretta
osteoarthritis of the knee
Zogenix
ZX008
Dravet syndrome
Keryx
chronic kidney disease
Auryxia

Pages